According to a new market research study titled ‘Sanger Sequencing Service Market to 2027 – Global Analysis and Forecasts by Application, End User, and Geography.’ The global Sanger sequencing service market is expected to reach US$ 1,360.47 Mn in 2027 from US$ 489.43 Mn in 2018. The market is forecasted to grow with a CAGR of 12.2% during 2019-2027. The report highlights the trends prevalent in the global Sanger sequencing service market and the factors driving the market along with those that act as deterrents to its growth.

Sanger sequencing is the technique through which selective incorporation of chain-terminating dideoxynucleotides is done using DNA polymerase during the process of in vitro DNA replication. Sanger sequencing is among the most common methods for detecting single nucleotide variants (SNVs). The technique is preferred in clinical genomics, as it helps in confirming sequence variants identified by NGS, and it also helps in sequencing the areas which have not been covered by NGS.

Get Sample PDF Report at :- https://www.theinsightpartners.com/sample/TIPRE00007514/?utm_source=Social&utm_medium=10489

Market leaders operating in the market have undertaken various organic growth strategies in the Sanger sequencing service market. Several organic approaches, such as product launches, and expansion/relocation in the Sanger sequencing service market, have resulted in the positive growth of the market. Product launches help the company to strengthen its product offering and the customer base, which allows the company to hold a strong position in the market. Similarly, utilizing expansion activities, it is easy to venture into untapped economies and use the opportunities being offered.

Sanger sequencing is the technique through which selective incorporation of chain-terminating dideoxynucleotides is done using DNA polymerase during the process of in vitro DNA replication. Sanger sequencing is among the most common methods for detecting single nucleotide variants (SNVs). The technique is preferred in clinical genomics, as it helps in confirming sequence variants identified by NGS, and it also helps in sequencing the areas which have not been covered by NGS.

The global Sanger sequencing service market, based on end user, was segmented as academic and government research institutes, hospitals and clinics, biotechnology companies and pharmaceutical companies and other end users. In 2018, academic and government research institutes segment led the market by end user owing to increasing R&D activities in these entities.

The major players operating in the Sanger sequencing service market include Microsynth AG, Laragen, Inc., StarSEQ GmbH, Thermo Fisher Scientific, Inc., LGC Biosearch Technologies, Fasteris SA, Quintara Biosciences, GENEWIZ, GenScript, and SciGenom Labs among others. The players in the market have undertaken strategic activities such as launches and expansion to improve their position in the Sanger sequencing service market. For instance, in January 2018, Microsynth is announced its innovative new sequencing service Ecoli NightSeq. Ecoli NightSeq is available for single tubes as well as for 96-well plates.

Below is the list of the growth strategies done by the players operating in the Sanger sequencing service market:

About The Insight Partners

The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in industries such as healthcare, media, and telecommunication.

Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis.

Our research content is majorly focused toward market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, product and service, radioisotope types, application and end user, which helps our clients to gain a deeper analytical understanding of various research topics.

Apart from the developments for the medical laser fibers market, the key market players are entering strategic partnerships and acquisitions and working towards developments of innovative laser fibers for medical use to cater the demands for the patients. For instance, one of the milestone acquisition of C.R. Bard by BD in December 2017 has led the company to hold one of the dominant shares in the medical laser fibers market through the revenue generated by PROFLEX Laser Fibers portfolio by C.R. Bard. Similar small and large level partnerships and acquisition are expected to generate turbulence and act as growth boosters in the global medical laser fibers market.

Some of the prominent players operating in the medical laser fibers market are Clarion Medical Technologies, Lumenis, biolitec AG, BD, Boston Scientific Corporation, Olympus Corporation, Cook, KARL STORZ SE & Co. KG, Richard Wolf GmbH, and IPG Photonics Corporation among others. The market players are focused on bringing new and innovative products and services through various inorganic strategies such as acquisitions and mergers to sustain their position in the market. For instance, in May 2017, Lumenis, one of the leading players offering energy-based medical devices, introduced its new Moses Holmium technology at the 112th American Urological Association (AUA) annual meeting in Boston

Contact Us

If you have any queries about this report or if you would like further information, please contact us:

North America: +1 646 491 9876

Asia Pacific: +91 20 6727 8686

Email: sales@theinsightpartners.com